| Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis AE Kudinov, A Deneka, AS Nikonova, TN Beck, YH Ahn, X Liu, ... Proceedings of the National Academy of Sciences 113 (25), 6955-6960, 2016 | 134 | 2016 |
| Mechanisms for nonmitotic activation of Aurora-A at cilia V Korobeynikov, AY Deneka, EA Golemis Biochemical Society Transactions 45 (1), 37-49, 2017 | 51 | 2017 |
| Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer AY Deneka, Y Baca, IG Serebriiskii, E Nicolas, MI Parker, TT Nguyen, ... Clinical Cancer Research 28 (9), 1925-1937, 2022 | 43 | 2022 |
| Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD) AS Nikonova, AY Deneka, AA Kiseleva, V Korobeynikov, A Gaponova, ... The FASEB Journal 32 (5), 2735, 2018 | 39 | 2018 |
| Targeting the epidermal growth factor receptor in EGFR-mutated lung cancer: current and emerging therapies K Khaddour, S Jonna, A Deneka, JD Patel, ME Abazeed, E Golemis, ... Cancers 13 (13), 3164, 2021 | 37 | 2021 |
| Tumor-targeted drug conjugates as an emerging novel therapeutic approach in small cell lung cancer (SCLC) AY Deneka, Y Boumber, T Beck, EA Golemis Cancers 11 (9), 1297, 2019 | 30 | 2019 |
| A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer AV Gaponova, AS Nikonova, AY Deneka, MC Kopp, AE Kudinov, ... Clinical Cancer Research 22 (20), 5120-5129, 2016 | 30 | 2016 |
| A comprehensive tyrosine phosphoproteomic analysis reveals novel components of the platelet CLEC-2 signaling cascade I Izquierdo, MN Barrachina, L Hermida-Nogueira, V Casas, LA Morán, ... Thrombosis and Haemostasis 120 (02), 262-276, 2020 | 27 | 2020 |
| Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members A Deneka, V Korobeynikov, EA Golemis Gene 570 (1), 25-35, 2015 | 27 | 2015 |
| Synthetic lethal targeting of mitotic checkpoints in HPV-negative head and neck cancer AY Deneka, MB Einarson, J Bennett, AS Nikonova, M Elmekawy, Y Zhou, ... Cancers 12 (2), 306, 2020 | 23 | 2020 |
| Unexpected activities in regulating ciliation contribute to off-target effects of targeted drugs AA Kiseleva, VA Korobeynikov, AS Nikonova, P Zhang, P Makhov, ... Clinical Cancer Research 25 (13), 4179-4193, 2019 | 22 | 2019 |
| Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC) P Makhov, I Bychkov, B Faezov, A Deneka, A Kudinov, E Nicolas, ... Oncogenesis 10 (3), 29, 2021 | 19 | 2021 |
| Opposing effects of inhibitors of Aurora-A and EGFR in autosomal-dominant polycystic kidney disease AS Nikonova, AY Deneka, L Eckman, MC Kopp, HH Hensley, BL Egleston, ... Frontiers in oncology 5, 228, 2015 | 16 | 2015 |
| Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer AY Deneka, MC Kopp, AS Nikonova, AV Gaponova, AA Kiseleva, ... Cancer research 81 (13), 3717-3726, 2021 | 11 | 2021 |
| Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin AV Gaponova, AY Deneka, TN Beck, H Liu, G Andrianov, AS Nikonova, ... Oncotarget 8 (12), 19156, 2017 | 11 | 2017 |
| Correlation of tumor mutational burden (TMB) with CDKN2A and TP53 mutation in HPV-negative head and neck squamous cell carcinoma (HNSCC). B Burtness, A Deneka, Y Baca, I Serebriiskii, MI Parker, E Nicolas, JW Lee, ... Journal of Clinical Oncology 38 (15_suppl), 6552-6552, 2020 | 9 | 2020 |
| Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model AY Deneka, L Haber, MC Kopp, AV Gaponova, AS Nikonova, EA Golemis PLoS One 12 (4), e0176747, 2017 | 9 | 2017 |
| NEDD9 sustains hexokinase expression to promote glycolysis AY Deneka, AS Nikonova, HO Lee, WD Kruger, EA Golemis Oncogenesis 11 (1), 15, 2022 | 7 | 2022 |
| Evaluation of the small-molecule BRD4 degrader CFT-2718 in small-cell lung cancer and pancreatic cancer models D Sun, AS Nikonova, P Zhang, AY Deneka, ME Fitzgerald, RE Michael, ... Molecular cancer therapeutics 20 (8), 1367-1377, 2021 | 7 | 2021 |
| Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC) I Topchu, N Karnaukhov, A Mazitova, V Yugai, M Voloshin, M Tikhomirova, ... Journal of Thoracic Disease 13 (3), 1370, 2021 | 7 | 2021 |
Erica GolemisProfessor, Assoc. Director for System Integration, Fox Chase Cancer Center, and Chair, LKSOM在 fccc.edu 的电子邮件经过验证
